🧠 Global Lisdexamfetamine Dimesylate market is projected to grow from USD 1.52 billion in 2023 to USD 2.31 billion by 2030, fueled by rising ADHD diagnosis rates and growing adoption of advanced CNS stimulant therapies.🔍 Key growth drivers:• Increasing awareness and diagnosis of ADHD worldwide• Growing demand for adult ADHD treatment solutions• Expanding use of prodrug stimulant formulations with improved safety profiles• Rising accessibility through telemedicine and modern healthcare systemsRead Full Report:https://www.24chemicalresearch.com/reports/271539/global-lisdexamfetamine-dimesylate-forecast-market-2024-2030-743#ADHD #PharmaceuticalMarket #CNSStimulants #HealthcareIndustry